Covestor LTD Immunity Bio, Inc. Transaction History
Covestor LTD
- $155 Million
- Q2 2024
A detailed history of Covestor LTD transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Covestor LTD holds 35 shares of IBRX stock, worth $119. This represents 0.0% of its overall portfolio holdings.
Number of Shares
35
Previous 35
-0.0%
Holding current value
$119
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding IBRX
# of Institutions
217Shares Held
63.3MCall Options Held
1.43MPut Options Held
4.12M-
Vanguard Group Inc Valley Forge, PA13.8MShares$47 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$38.8 Million0.0% of portfolio
-
State Street Corp Boston, MA7.86MShares$26.7 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.92MShares$13.3 Million0.0% of portfolio
-
Jane Street Group, LLC New York, NY1.72MShares$5.83 Million0.01% of portfolio
About ImmunityBio, Inc.
- Ticker IBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 400,304,000
- Market Cap $1.36B
- Description
- ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...